HK1244706A1 - 用於治療勃起功能障礙的組成物及方法 - Google Patents

用於治療勃起功能障礙的組成物及方法

Info

Publication number
HK1244706A1
HK1244706A1 HK18104341.8A HK18104341A HK1244706A1 HK 1244706 A1 HK1244706 A1 HK 1244706A1 HK 18104341 A HK18104341 A HK 18104341A HK 1244706 A1 HK1244706 A1 HK 1244706A1
Authority
HK
Hong Kong
Prior art keywords
compositions
methods
erectile dysfunction
treating erectile
treating
Prior art date
Application number
HK18104341.8A
Other languages
English (en)
Inventor
Jacob Rajfer
Original Assignee
K L R M Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by K L R M Llc filed Critical K L R M Llc
Publication of HK1244706A1 publication Critical patent/HK1244706A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A61K36/575—Magnolia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK18104341.8A 2010-10-19 2014-02-22 用於治療勃起功能障礙的組成物及方法 HK1244706A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/907,113 US20120093950A1 (en) 2010-10-19 2010-10-19 Compositions and methods for treating, inhibiting the onset, and slowing the progression of erectile dysfunction including naturally occuring age related erectile dysfunction

Publications (1)

Publication Number Publication Date
HK1244706A1 true HK1244706A1 (zh) 2018-08-17

Family

ID=45934358

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18104341.8A HK1244706A1 (zh) 2010-10-19 2014-02-22 用於治療勃起功能障礙的組成物及方法

Country Status (10)

Country Link
US (3) US20120093950A1 (zh)
EP (1) EP2637505B1 (zh)
KR (2) KR101975729B1 (zh)
CN (2) CN103402530B (zh)
CA (1) CA2815340C (zh)
ES (1) ES2549193T3 (zh)
HK (1) HK1244706A1 (zh)
MX (1) MX347021B (zh)
TW (1) TWI538681B (zh)
WO (1) WO2012067745A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572848B1 (en) 2014-03-26 2017-02-21 Aemes Research L.L.L.P. Composition of matter for sexual dysfunction
WO2016120844A1 (en) * 2015-01-29 2016-08-04 Giovanni Ferrari Energizing mixture, particulary on sexual level
US20180078602A1 (en) * 2015-03-04 2018-03-22 K.L.R.M., Llc Methods and compositions for extending the efficacy of phosphodiesterase inhibitors for treating erectile dysfunction, and compositions for inhibiting the onset and slowing the progression of erectile dysfunction
KR102491748B1 (ko) * 2016-09-29 2023-01-25 케이.엘.알.엠., 엘엘씨 정형외과적 질병의 치료를 위한 조성물 및 방법
ES2749717A1 (es) 2018-09-21 2020-03-23 Biopeptide S L Composición y sus usos
KR20210126644A (ko) * 2019-02-06 2021-10-20 케이.엘.알.엠., 엘엘씨 변비 및 위장계의 다른 질병의 치료를 위한 조성물 및 방법
WO2022027122A1 (en) * 2020-08-06 2022-02-10 Ramade & Cia Holding Corp. Compositions with cannabinoids of cannabis sativa for treating erectile and sexual dysfunction
KR102580664B1 (ko) * 2023-01-25 2023-09-21 (주)나인팩토리커뮤니케이션 남성 성기에 부종감 및 온열감을 주고 혈행을 개선하는 피부 외용제 조성물

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814366A (en) 1986-10-07 1989-03-21 Mitsubishi Chemical Industries Limited Thermoplastic polyester resin composition
US5594032A (en) 1994-11-10 1997-01-14 Gonzalez-Cadavid; Nestor F. Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA
JP4484254B2 (ja) 1995-12-06 2010-06-16 佐々木化学工業株式会社 アミノ酸組成剤
US6133281A (en) 1996-10-24 2000-10-17 Harbor-Ucla Research And Education Institute NMDA receptor blockers in the therapy of urogenital disease
ZA995697B (en) 1998-06-03 2000-04-13 Andries Matthys Booyens A valve.
US6007824A (en) 1998-07-09 1999-12-28 Duckett; Melvin J. Natural composition and method for the treatment of sexual dysfunction
ZA994697B (en) * 1998-09-09 2000-01-31 Pharmachoice Healthcare Pty Lt Pharmaceutical formulation.
WO2000035466A1 (en) * 1998-12-11 2000-06-22 Peya Biotech Inc. Aframomum seeds for improving penile activity
US6210701B1 (en) 1999-04-30 2001-04-03 Healthcomm International, Inc. Medical food for treating inflammation-related diseases
JP2000316528A (ja) * 1999-05-06 2000-11-21 Takeshi Fujii 生殖機能増強栄養補助食品
JP4788039B2 (ja) 1999-05-10 2011-10-05 日本新薬株式会社 減退生殖機能回復用組成物
JP2002193826A (ja) 2000-12-26 2002-07-10 Fancl Corp 強壮・強精組成物
US6809079B2 (en) 2002-01-08 2004-10-26 Vasogenix Pharmaceuticals, Inc. Compositions and methods for treating female sexual arousal disorder using hydrophobic-calcitonin gene related peptide
CA2390350A1 (en) 2002-06-10 2003-12-10 Ibm Canada Limited-Ibm Canada Limitee Incremental cardinality estimation for a set of data values
US8133903B2 (en) 2003-10-21 2012-03-13 Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases
WO2004071437A2 (en) * 2003-02-07 2004-08-26 Barmensen, Inc. Compositions for enhancing sexual responsiveness
US20090274722A1 (en) 2007-01-29 2009-11-05 Ligums John E Therapeutic Composition for the Treatment of BPH and ED
JPWO2008105384A1 (ja) * 2007-02-26 2010-06-03 協和発酵バイオ株式会社 シトルリン含有錠剤
US20100129467A9 (en) * 2007-08-31 2010-05-27 Albritton Iv Ford D Nutritional supplement
EP3320895B1 (en) 2007-10-10 2021-03-10 Kyowa Hakko Bio Co., Ltd. Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine
CN101167714A (zh) * 2007-10-19 2008-04-30 武汉大学 一种治疗男性勃起功能障碍的药物
ITMI20080567A1 (it) * 2008-04-02 2009-10-03 Androsystems Srl L-citrullina per il trattamento della disfunzione endoteliale e della disfunzione erettile.
GB2461021A (en) 2008-06-10 2009-12-23 Ajit Lalvani Composition for the treatment of hair loss and baldness
JP5620647B2 (ja) * 2009-01-30 2014-11-05 ハウス食品グループ本社株式会社 眠気覚まし用組成物
CN101822656A (zh) * 2009-03-06 2010-09-08 北京卓越同创药物研究院 姜黄素的用途
CN101642226A (zh) * 2009-06-19 2010-02-10 天津春发食品配料有限公司 一种天然猪肉味香精
CN101642228A (zh) * 2009-06-19 2010-02-10 天津春发食品配料有限公司 一种天然虾肉味香精的制备方法
US20120121740A1 (en) 2010-10-19 2012-05-17 K.L.R.M., Llc Compositions and methods for treating, inhibiting the onset, and slowing the progression of erectile dysfunction including naturally occurring age related erectile dysfunction

Also Published As

Publication number Publication date
CN103402530A (zh) 2013-11-20
ES2549193T3 (es) 2015-10-23
EP2637505A1 (en) 2013-09-18
EP2637505A4 (en) 2014-04-09
KR20180049149A (ko) 2018-05-10
US20190307829A1 (en) 2019-10-10
MX2013004306A (es) 2013-11-04
TW201223536A (en) 2012-06-16
CA2815340A1 (en) 2012-05-24
US20140255528A1 (en) 2014-09-11
US10406196B2 (en) 2019-09-10
KR101975729B1 (ko) 2019-05-07
CA2815340C (en) 2022-07-05
KR20140020232A (ko) 2014-02-18
MX347021B (es) 2017-04-07
CN103402530B (zh) 2017-07-28
WO2012067745A1 (en) 2012-05-24
US20120093950A1 (en) 2012-04-19
EP2637505B1 (en) 2015-08-05
KR101853851B1 (ko) 2018-05-02
TWI538681B (zh) 2016-06-21
US10973866B2 (en) 2021-04-13
CN107537013A (zh) 2018-01-05

Similar Documents

Publication Publication Date Title
HK1246715A1 (zh) 用於靶向熱調節的組合物和方法
HK1201475A1 (zh) 治療疼痛的方法和組合物
EP2655334A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
EP2603202A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF TAUOPATHIES
SG10201500048SA (en) Compositions and methods for treating glioblastoma gbm
ZA201303423B (en) Compositions and methods for treating myelofibrosis
HK1244706A1 (zh) 用於治療勃起功能障礙的組成物及方法
EP2575825A4 (en) COMPOSITIONS AND METHODS FOR TREATING DEPRESSION
SG10201500124VA (en) Methods and Compositions for Treating Cancer
EP2504428A4 (en) METHOD AND COMPOSITIONS FOR TREATING OXALATE-MEDIATED SUFFERING
EP2544655A4 (en) COMPOSITIONS AND METHODS FOR TREATING SKIN
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
EP2590674A4 (en) COMPOSITIONS AND METHODS FOR INFLUENZA TREATMENT
IL216146A0 (en) Methods and compositions for treating lupus
EP2555788A4 (en) METHOD AND COMPOSITIONS FOR THE PROTECTION AND REGENERATION OF THE HEART
EP2632460A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF TUBERCULOSIS
HK1183766A1 (zh) 用於治療瘀傷的組合物和方法
ZA201305497B (en) Methods and compositions for preventing and treating osteoarthritis
IL225483A0 (en) The compositions and methods for the treatment of neoplasia
EP2666776A4 (en) PYRAZOLOPYRIMIDINONE COMPOUND AND IMIDAZOTRIAZONE COMPOUND FOR THE TREATMENT OF THE EFFECTIVE DYSFUNCTION
EP2608794A4 (en) METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF OBESITY
PL2606032T3 (pl) Kompozycja i sposoby terapii glejakaep
EP2654899A4 (en) METHODS OF TREATING NEUROLOGICAL CONDITIONS AND COMPOSITIONS AND PRODUCTS USED THEREFOR
EP2582384A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
EP2585109A4 (en) COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING ORGAN DAMAGE AND / OR DYSFUNCTION